• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在现实环境中,当相关心血管危险因素增加时,他汀类药物的依从性更好:一项队列研究。

Adherence with statins in a real-life setting is better when associated cardiovascular risk factors increase: a cohort study.

机构信息

Univ. de Bordeaux, Bordeaux, France.

出版信息

BMC Cardiovasc Disord. 2011 Jul 26;11:46. doi: 10.1186/1471-2261-11-46.

DOI:10.1186/1471-2261-11-46
PMID:21791073
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3160410/
Abstract

BACKGROUND

While the factors for poor adherence for treatment with statins have been highlighted, the impact of their combination on adherence is not clear.

AIMS

To estimate adherence for statins and whether it differs according to the number of cardiovascular risk factors.

METHODS

A cohort study was conducted using data from the main French national health insurance system reimbursement database. Newly treated patients with statins between September 1 and December 31, 2004 were included. Patients were followed up 15 months. The cohort was split into three groups according to their number of additional cardiovascular risk factors that included age and gender, diabetes mellitus and cardiovascular disease (using co-medications as a proxy). Adherence was assessed for each group by using four parameters: (i) proportion of days covered by statins, (ii) regularity of the treatment over time, (iii) persistence, and (iv) the refill delay.

RESULTS

16,397 newly treated patients were identified. Of these statin users, 21.7% did not have additional cardiovascular risk factors. Thirty-one percent had two cardiovascular risk factors and 47% had at least three risk factors. All the parameters showed a sub-optimal adherence whatever the group: days covered ranged from 56% to 72%, regularity ranged from 23% to 33% and persistence ranged from 44% to 59%, but adherence was better for those with a higher number of cardiovascular risk factors.

CONCLUSIONS

The results confirm that long-term drug treatments are a difficult challenge, particularly in patients at lower risk and invite to the development of therapeutic education.

摘要

背景

尽管已经强调了他汀类药物治疗依从性差的因素,但它们联合使用对依从性的影响尚不清楚。

目的

评估他汀类药物的依从性,以及它是否因心血管危险因素的数量而异。

方法

采用法国主要国家健康保险系统报销数据库中的数据进行队列研究。纳入 2004 年 9 月 1 日至 12 月 31 日期间新接受他汀类药物治疗的患者。患者随访 15 个月。该队列根据其附加心血管危险因素的数量分为三组,包括年龄和性别、糖尿病和心血管疾病(使用合并用药作为替代指标)。通过使用以下四个参数评估每个组的依从性:(i)他汀类药物覆盖的天数比例,(ii)随着时间的推移治疗的规律性,(iii)持久性,以及(iv)补充延迟。

结果

共确定了 16397 名新接受他汀类药物治疗的患者。在这些他汀类药物使用者中,21.7%没有其他心血管危险因素。31%有两个心血管危险因素,47%有至少三个危险因素。无论组内情况如何,所有参数均显示出次优的依从性:覆盖天数从 56%到 72%不等,规律性从 23%到 33%不等,持久性从 44%到 59%不等,但在心血管危险因素数量较高的患者中,依从性更好。

结论

研究结果证实,长期药物治疗是一项艰巨的挑战,特别是对风险较低的患者,这需要开展治疗教育。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa7e/3160410/3756a692399d/1471-2261-11-46-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa7e/3160410/3756a692399d/1471-2261-11-46-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa7e/3160410/3756a692399d/1471-2261-11-46-1.jpg

相似文献

1
Adherence with statins in a real-life setting is better when associated cardiovascular risk factors increase: a cohort study.在现实环境中,当相关心血管危险因素增加时,他汀类药物的依从性更好:一项队列研究。
BMC Cardiovasc Disord. 2011 Jul 26;11:46. doi: 10.1186/1471-2261-11-46.
2
Real-world evaluation of the impact of statin intensity on adherence and persistence to therapy: A Scottish population-based study.真实世界评估他汀类药物强度对治疗依从性和持久性的影响:一项苏格兰基于人群的研究。
Br J Clin Pharmacol. 2020 Dec;86(12):2349-2361. doi: 10.1111/bcp.14333. Epub 2020 May 30.
3
Treatment persistence and adherence and their consequences on patient outcomes of generic versus brand-name statins routinely used to treat high cholesterol levels in Spain: a retrospective cost-consequences analysis.在西班牙,常规使用通用名和品牌名他汀类药物治疗高胆固醇水平,本回顾性成本后果分析评估了这些药物在治疗持续性和患者依从性及其对患者结局的影响。
Lipids Health Dis. 2018 Dec 6;17(1):277. doi: 10.1186/s12944-018-0918-y.
4
Statins and the risk of diabetes: evidence from a large population-based cohort study.他汀类药物与糖尿病风险:来自大型基于人群队列研究的证据。
Diabetes Care. 2014 Aug;37(8):2225-32. doi: 10.2337/dc13-2215. Epub 2014 Jun 26.
5
Association of a Combined Measure of Adherence and Treatment Intensity With Cardiovascular Outcomes in Patients With Atherosclerosis or Other Cardiovascular Risk Factors Treated With Statins and/or Ezetimibe.联合用药依从性和治疗强度指标与他汀类药物和/或依折麦布治疗的动脉粥样硬化或其他心血管危险因素患者心血管结局的相关性。
JAMA Netw Open. 2018 Dec 7;1(8):e185554. doi: 10.1001/jamanetworkopen.2018.5554.
6
[Achievement of therapeutic target in subjects on statin treatment in clinical practice. Results of the STAR (Statins Target Assessment in Real practice) study].[临床实践中接受他汀类药物治疗患者的治疗目标达成情况。STAR(真实实践中的他汀类药物目标评估)研究结果]
Monaldi Arch Chest Dis. 2011 Dec;76(4):160-7. doi: 10.4081/monaldi.2011.172.
7
Balancing cardiovascular benefit and diabetogenic harm of therapy with statins: Real-world evidence from Italy.用他汀类药物治疗的心血管获益与致糖尿病危害的平衡:来自意大利的真实世界证据。
Diabetes Res Clin Pract. 2020 Jun;164:108197. doi: 10.1016/j.diabres.2020.108197. Epub 2020 May 8.
8
Results of a retrospective database analysis of adherence to statin therapy and risk of nonfatal ischemic heart disease in daily clinical practice in Italy.意大利日常临床实践中他汀类药物治疗依从性与非致命性缺血性心脏病风险的回顾性数据库分析结果。
Clin Ther. 2010 Feb;32(2):300-10. doi: 10.1016/j.clinthera.2010.02.004.
9
Factors associated with 2-year persistence in fully non reimbursed lipid-lowering treatments.与完全自费降脂治疗 2 年持续相关的因素。
Atherosclerosis. 2014 Jul;235(1):81-3. doi: 10.1016/j.atherosclerosis.2014.04.016. Epub 2014 Apr 26.
10
Assessment of Trends in Statin Therapy for Secondary Prevention of Atherosclerotic Cardiovascular Disease in US Adults From 2007 to 2016.评估 2007 年至 2016 年美国成年人中他汀类药物用于动脉粥样硬化性心血管疾病二级预防的趋势。
JAMA Netw Open. 2020 Nov 2;3(11):e2025505. doi: 10.1001/jamanetworkopen.2020.25505.

引用本文的文献

1
The Dynamics of Cardiovascular Risk-An Analysis of the Prospective Urban Rural Epidemiology (PURE) Poland Cohort Study.心血管风险动态——前瞻性城乡流行病学(PURE)波兰队列研究分析
J Clin Med. 2024 Jun 26;13(13):3728. doi: 10.3390/jcm13133728.
2
Persistence and Adherence to Cardiovascular Medicines in Australia.澳大利亚心血管药物的坚持和依从性。
J Am Heart Assoc. 2023 Jul 4;12(13):e030264. doi: 10.1161/JAHA.122.030264. Epub 2023 Jun 29.
3
Medication Adherence for Haemophilia Patients: Outcome of Prophylaxis Treatment Intervention.

本文引用的文献

1
Improving the prediction of medication compliance: the example of bisphosphonates for osteoporosis.提高药物依从性的预测:以双膦酸盐治疗骨质疏松症为例。
Med Care. 2009 Mar;47(3):334-41. doi: 10.1097/MLR.0b013e31818afa1c.
2
Long-term adherence to statin treatment in diabetes.糖尿病患者长期坚持他汀类药物治疗
Diabet Med. 2008 Jul;25(7):850-5. doi: 10.1111/j.1464-5491.2008.02476.x.
3
Adherence to statin therapy and patients' cardiovascular risk: a pharmacoepidemiological study in Italy.他汀类药物治疗的依从性与患者的心血管风险:意大利的一项药物流行病学研究。
血友病患者的药物依从性:预防性治疗干预的结果
Healthcare (Basel). 2021 Dec 8;9(12):1702. doi: 10.3390/healthcare9121702.
4
Determinants of Non-Adherence to the Medications for Dyslipidemia: A Systematic Review.血脂异常药物治疗不依从性的决定因素:一项系统评价
Patient Prefer Adherence. 2021 Aug 24;15:1853-1871. doi: 10.2147/PPA.S319604. eCollection 2021.
5
Assessment of Medication Adherence in Patients with Chronic Diseases in Tabuk, Kingdom of Saudi Arabia.沙特阿拉伯王国塔布克慢性病患者用药依从性评估
J Res Pharm Pract. 2021 Jan 11;9(4):196-201. doi: 10.4103/jrpp.JRPP_20_97. eCollection 2020 Oct-Dec.
6
Real-world evaluation of the impact of statin intensity on adherence and persistence to therapy: A Scottish population-based study.真实世界评估他汀类药物强度对治疗依从性和持久性的影响:一项苏格兰基于人群的研究。
Br J Clin Pharmacol. 2020 Dec;86(12):2349-2361. doi: 10.1111/bcp.14333. Epub 2020 May 30.
7
Medication adherence in chronic illness: do beliefs about medications play a role?慢性病中的药物依从性:对药物的认知是否起作用?
Patient Prefer Adherence. 2018 Sep 5;12:1687-1698. doi: 10.2147/PPA.S169236. eCollection 2018.
8
Treatment gaps and potential cardiovascular risk reduction from expanded statin use in the US and England.在美国和英国,扩大他汀类药物的使用可减少治疗差距和潜在的心血管风险。
PLoS One. 2018 Mar 21;13(3):e0190688. doi: 10.1371/journal.pone.0190688. eCollection 2018.
9
The impact of the time of drug administration on the effectiveness of combined treatment of hypercholesterolemia with Rosuvastatin and Ezetimibe (RosEze): study protocol for a randomized controlled trial.药物给药时间对瑞舒伐他汀和依折麦布联合治疗高胆固醇血症(RosEze)有效性的影响:一项随机对照试验的研究方案
Trials. 2017 Jul 11;18(1):316. doi: 10.1186/s13063-017-2047-8.
10
Residual cardiovascular risk in patients who received lipid-lowering treatment in a real-life setting: retrospective study.现实生活中接受降脂治疗患者的残余心血管风险:一项回顾性研究。
Clinicoecon Outcomes Res. 2016 Oct 25;8:649-655. doi: 10.2147/CEOR.S107992. eCollection 2016.
Eur J Clin Pharmacol. 2008 Apr;64(4):425-32. doi: 10.1007/s00228-007-0428-8. Epub 2008 Jan 5.
4
Factors related to adherence to statin therapy.与他汀类药物治疗依从性相关的因素。
Ann Pharmacother. 2007 Nov;41(11):1805-11. doi: 10.1345/aph.1K209. Epub 2007 Oct 9.
5
Persistent use of evidence-based pharmacotherapy in heart failure is associated with improved outcomes.持续使用循证药物疗法治疗心力衰竭与改善预后相关。
Circulation. 2007 Aug 14;116(7):737-44. doi: 10.1161/CIRCULATIONAHA.106.669101. Epub 2007 Jul 23.
6
Evaluation of the prescription and utilization patterns of statins in an Italian local health unit during the period 1994-2003.1994年至2003年期间意大利某地方卫生单位他汀类药物的处方及使用模式评估。
Eur J Clin Pharmacol. 2007 Feb;63(2):197-203. doi: 10.1007/s00228-006-0239-3. Epub 2007 Jan 3.
7
Comparison of measures of medication persistency using a prescription drug database.
Am Heart J. 2007 Jan;153(1):59-65. doi: 10.1016/j.ahj.2006.10.018.
8
Adherence to evidence-based statin guidelines reduces the risk of hospitalizations for acute myocardial infarction by 40%: a cohort study.一项队列研究表明,遵循循证他汀类药物指南可将急性心肌梗死住院风险降低40%。
Eur Heart J. 2007 Jan;28(2):154-9. doi: 10.1093/eurheartj/ehl391. Epub 2006 Dec 7.
9
Adherence to chronic cardiovascular therapies: persistence over the years and dose coverage.慢性心血管疾病治疗的依从性:多年来的持续性和剂量覆盖情况。
Br J Clin Pharmacol. 2007 Mar;63(3):346-55. doi: 10.1111/j.1365-2125.2006.02801.x. Epub 2006 Nov 10.
10
Measurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measures.药房管理数据库中依从性的测量:标准定义和首选测量方法的建议
Ann Pharmacother. 2006 Jul-Aug;40(7-8):1280-88. doi: 10.1345/aph.1H018.